Researchers at Mayo Clinic have discovered a novel therapeutic approach that repurposes a sugar-coating mechanism known from cancer biology to protect pancreatic beta cells from immune attack in type 1 diabetes. This innovative technique employs sialic acid molecules to shield cells from autoimmune destruction, opening potential avenues for treatment in autoimmune diseases by leveraging cancer cell evasion strategies.